Key result
Low dose, prolonged infusion of tissue plasminogen activator uneventfully treated a 42-year-old woman presenting with acute ST-elevation inferior myocardial infarction due to coronary embolism.
Population
1 42-year-old woman with non-obstructive prosthetic mechanical mitral valve thrombosis presenting as…
Design
Case_report
Authors
Loading...
Suggests potential role for low-dose prolonged tPA in coronary embolism STEMI; hypothesis-generating and should not yet alter practice.
Case Report (n=1)
Low-dose, prolonged infusion of tissue plasminogen activator can be an effective treatment for coronary embolism and acute STEMI resulting from non-obstructive prosthetic mitral valve thrombosis.
Aykan et al. (2012) conducted a case report in Acute ST-elevation inferior myocardial infarction due to non-obstructive mechanical mitral valve thrombosis (n=1). Tissue plasminogen activator was evaluated on Clinical outcome. Low dose, prolonged infusion of tissue plasminogen activator uneventfully treated a 42-year-old woman presenting with acute ST-elevation inferior myocardial infarction due to coronary embolism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: